ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · see citing works

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160 · see citing works

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108 · see citing works

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works

Genomic analyses identify molecular subtypes of pancreatic cancer

Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621 · see citing works

Laser Capture Microdissection

Emmert‐Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., & Liotta, L. A. (1996) · Science · doi:10.1126/science.274.5289.998 · Cited by 2,540 · see citing works

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471 · see citing works

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy

Kadoch, C., Hargreaves, D. C., Hodges, H. C., Elias, L., Ho, L., Ranish, J. A., & Crabtree, G. R. (2013) · Nature Genetics · doi:10.1038/ng.2628 · Cited by 1,443 · see citing works

SWI/SNF nucleosome remodellers and cancer

Wilson, B. G., & Roberts, C. W. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3068 · Cited by 1,286 · see citing works

TGFβ signalling: a complex web in cancer progression

Ikushima, H., & Miyazono, K. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2853 · Cited by 1,170 · see citing works

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, A. K., McMillan, E. A., Balaji, U., Baek, G., Lin, W.-C., Mansour, J., Mollaee, M., Wagner, K.-U., Koduru, P., Yopp, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7744 · Cited by 1,115 · see citing works

The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors

Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R. J., & Wright, C. V. E. (2002) · Nature Genetics · doi:10.1038/ng959 · Cited by 1,007 · see citing works

β-Cell-specific inactivation of the mouseIpf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetesPreprint

Ahlgren, U., Jönsson, J., Jönsson, L., Simu, K., & Edlund, H. (1998) · Genes & Development · doi:10.1101/gad.12.12.1763 · Cited by 918 · see citing works

Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma

Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697 · see citing works

The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers

Shain, A. H., & Pollack, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055119 · Cited by 578 · see citing works

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

Morris, J. P., Wang, S. C., & Hebrok, M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2899 · Cited by 567 · see citing works

Oncogenic Mutations of PIK3CA in Human Cancers

Samuels, Y., & Velculescu, V. E. (2004) · Cell Cycle · doi:10.4161/cc.3.10.1164 · Cited by 539 · see citing works

Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression

Fukuda, A., Wang, S. C., Morris, J. P., Folias, A. E., Liou, A., Kim, G. E., Akira, S., Boucher, K., Firpo, M., Mulvihill, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.002 · Cited by 531 · see citing works

Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth.

Solar, M., Cardalda, C., Houbracken, I., Martín, M., Maestro, M., Demedts, N., Xu, X.-B., Grau, V., Heimberg, H., Bouwens, L., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.11.003 · Cited by 516 · see citing works

Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

Hidalgo, M. M., Cascinu, S., Kleeff, J. H., Labianca, R., Löhr, M. J., Neoptolemos, J. P., Real, F. X., Laethem, J. V., & Heinemann, V. (2014) · Pancreatology · doi:10.1016/j.pan.2014.10.001 · Cited by 507 · see citing works

Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

Sausen, M., Phallen, J., Adleff, V., Jones, S., Leary, R. J., Barrett, M. T., Anagnostou, V., Parpart-Li, S., Murphy, D., Kay Li, Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms8686 · Cited by 484 · see citing works

ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?

Wu, J. N., & Roberts, C. W. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0361 · Cited by 457 · see citing works

Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice

Habbe, N., Shi, G., Meguid, R. A., Fendrich, V., Esni, F., Chen, H., Feldmann, G., Stoffers, D. A., Konieczny, S. F., Leach, S. D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810097105 · Cited by 410 · see citing works

KrasG12D and Smad4/Dpc4 Haploinsufficiency Cooperate to Induce Mucinous Cystic Neoplasms and Invasive Adenocarcinoma of the Pancreas

Izeradjene, K., Combs, C., Best, M., Gopinathan, A., Wagner, A., Grady, W. M., Deng, C.-X., Hruban, R. H., Adsay, N. V., Tuveson, D. A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.017 · Cited by 379 · see citing works

ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice

Mathur, R., Alver, B., Roman, A. K. S., Wilson, B. G., Wang, X., Agoston, A. T., Park, P. J., Shivdasani, R. A., & Roberts, C. W. M. (2016) · Nature Genetics · doi:10.1038/ng.3744 · Cited by 356 · see citing works

ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a

Gao, X., Tate, P. H., Hu, P., Tjian, R., Skarnes, W. C., & Wang, Z. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801802105 · Cited by 336 · see citing works

Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

Chandler, R. L., Damrauer, J. S., Raab, J. R., Schisler, J. C., Wilkerson, M. D., Didion, J. P., Starmer, J., Serber, D., Yee, D., Xiong, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7118 · Cited by 320 · see citing works

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

Asano, T., Yao, Y., Zhu, J., Li, D., Abbruzzese, J. L., & Reddy, S. A. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207902 · Cited by 303 · see citing works

Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration

Pan, F. C., Bankaitis, E., Boyer, D. F., Xu, X.-B., de Casteele, M. V., Magnuson, M., Heimberg, H., & Wright, C. (2013) · Development · doi:10.1242/dev.090159 · Cited by 299 · see citing works

A Specificity and Targeting Subunit of a Human SWI/SNF Family-Related Chromatin-Remodeling Complex

Nie, Z., Xue, Y., Yang, D., Zhou, S., Deroo, B. J., Archer, T., & Wang, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8879-8888.2000 · Cited by 298 · see citing works

Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia

Seeley, E. S., Carrière, C., Goetze, T., Longnecker, D. S., & Korc, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1290 · Cited by 283 · see citing works

A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation

Shih, H., Kopp, J. L., Sandhu, M., Dubois, C. L., Seymour, P. A., Grapin-Botton, A., & Sander, M. (2012) · Development · doi:10.1242/dev.078634 · Cited by 233 · see citing works

Stabilization of β-catenin impacts pancreas growth

Heiser, P. W., Lau, J., Taketo, M. M., Herrera, P. L., & Hebrok, M. (2006) · Development · doi:10.1242/dev.02366 · Cited by 225 · see citing works

Cystic precursors to invasive pancreatic cancer

Matthaei, H., Schulick, R. D., Hruban, R. H., & Maitra, A. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.2 · Cited by 193 · see citing works

Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance

Lim, K., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.014 · Cited by 191 · see citing works

The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma

von Figura, G., Fukuda, A., Roy, N., Liku, M. E., Morris IV, J. P., Kim, G. E., Russ, H. A., Firpo, M. A., Mulvihill, S. J., Dawson, D. W., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2916 · Cited by 190 · see citing works

SNF2β-BRG1 is Essential for the Viability of F9 Murine Embryonal Carcinoma Cells

Sumi‐Ichinose, C., Ichinose, H., METZGER, D., & Chambon, P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5976 · Cited by 165 · see citing works

Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.

Okami, K., Wu, L. J., Riggins, G. J., Cairns, P., Goggins, M., Evron, E., Halachmi, N., Ahrendt, S. A., Reed, A. L., Hilgers, W., et al. (1998) · PubMed · Cited by 163 · see citing works

Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation

Roy, N., Malik, S., Villanueva, K. E., Urano, A., Lu, X., Von Figura, G., Seeley, E. S., Dawson, D. W., Collisson, E. A., & Hebrok, M. (2015) · Genes & Development · doi:10.1101/gad.256628.114 · Cited by 155 · see citing works

Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma

Walter, D. M., Venancio, O. S., Buza, E. L., Tobias, J. W., Deshpande, C. G., Gudiel, A. A., Kim-Kiselak, C., Cicchini, M., Yates, T. J., & Feldser, D. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2159 · Cited by 144 · see citing works

Intraductal papillary mucinous neoplasm

Shi, C., & Hruban, R. H. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.04.003 · Cited by 133 · see citing works

Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis

Guan, B., Rahmanto, Y. S., Wu, R., Wang, Y., Wang, Z., Wang, T., & Shih, I. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju146 · Cited by 125 · see citing works

sox9b Is a Key Regulator of Pancreaticobiliary Ductal System Development

Delous, M., Yin, C., Shin, D., Ninov, N., Carten, J. D., Pan, L., Ma, T. P., Farber, S. A., Moens, C. B., & Stainier, D. Y. R. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002754 · Cited by 120 · see citing works

Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer

Bruns, C. J., Koehl, G. E., Guba, M. O., Yezhelyev, M., Steinbauer, M. G. M., Seeliger, H., Schwend, A., Hoehn, A., Jauch, K., & Geissler, E. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0502 · Cited by 115 · see citing works

ARID1a-DNA Interactions Are Required for Promoter Occupancy by SWI/SNF

Chandler, R. L., Brennan, J. A., Schisler, J. C., Serber, D., Patterson, C., & Magnuson, T. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01008-12 · Cited by 110 · see citing works

Reconstitution of Glucocorticoid Receptor-Dependent Transcription In Vivo

Trotter, K. W., & Archer, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3347-3358.2004 · Cited by 107 · see citing works

Isolation, culture and genetic manipulation of mouse pancreatic ductal cells

Reichert, M., Takano, S., Heeg, S., Bakir, B. S., Botta, G., & Rustgi, A. (2013) · Nature Protocols · doi:10.1038/nprot.2013.079 · Cited by 89 · see citing works

A transgenic mouse model for mammary carcinogenesis

Li, B., Murphy, K. L., Laucirica, R., Kittrell, F. S., Medina, D., & Rosen, J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1201621 · Cited by 89 · see citing works

p300/CREB Binding Protein-Related Protein p270 Is a Component of Mammalian SWI/SNF Complexes

Dallas, P. B., Cheney, I. W., Liao, D.-W., Bowrin, V., Byam, W., Pacchione, S. J., Kobayashi, R., Yaciuk, P., & Morán, E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3596 · Cited by 88 · see citing works

Loss of Pten and activation of kras synergistically induce formation of intraductal papillary mucinous neoplasia from pancreatic ductal cells in mice

Kopp, J. L., Dubois, C. L., Schaeffer, D. F., Samani, A., Taghizadeh, F., Cowan, R. W., Rhim, A. D., Stiles, B. L., Valasek, M., & Sander, M. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.12.007 · Cited by 80 · see citing works

The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation.

Asano, T., Yao, Y.-X., Zhu, J.-J., Li, D.-H., Abbruzzese, J., & Reddy, S. A. (2005) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2005.03.166 · Cited by 74 · see citing works

Intraductal Papillary-Mucinous Neoplasms of the Gastric and Intestinal Types May Have Less Malignant Potential Than the Pancreatobiliary Type

Takasu, N., Kimura, W., Moriya, T., Hirai, I., Takeshita, A., Kamio, Y., & Nomura, T. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c6947a · Cited by 53 · see citing works

Generation of transgenic mice for conditional overexpression of Sox9

Kim, Y., Murao, H., Yamamoto, K., Deng, J. M., Behringer, R. R., Nakamura, T., & Akiyama, H. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0206-z · Cited by 53 · see citing works

Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice

Yamaguchi, J., Mino-Kenudson, M. A., Liss, A. S., Chowdhury, S., Wang, T. C., Castillo, C. F. F.-D., Lillemoe, K. D., Warshaw, A. L., & Thayer, S. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.045 · Cited by 50 · see citing works

Culturing Primary Mouse Pancreatic Ductal CellsPreprint

Reichert, M., Rhim, A. D., & Rustgi, A. K. (2015) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot078279 · Cited by 13 · see citing works

A CRISPR/Cas9-Engineered <i>ARID1A</i> -Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation

Lo, Y.-H., Kolahi, K. S., Du, Y., Chang, C.-Y., Krokhotin, A., Nair, A., Sobba, W. D., Karlsson, K., Jones, S. J., Longacre, T. A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1109 · Cited by 174 · see citing works

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

Yousef, A., Yousef, M., Chowdhury, S., Abdilleh, K., Knafl, M., Edelkamp, P., Alfaro-Munoz, K., Chacko, R., Peterson, J., Smaglo, B. G., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00505-0 · Cited by 93 · see citing works

ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas.

Wang, W., Friedland, S. C., Guo, B., O'Dell, M. R., Alexander, W. B., Whitney-Miller, C. L., Agostini-Vulaj, D., Huber, A. R., Myers, J. R., Ashton, J., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315541 · Cited by 70 · see citing works

SWI/SNF component <i>ARID1A</i> restrains pancreatic neoplasia formation

Wang, S. C., Nassour, I., Xiao, S., Zhang, S., Luo, X., Lee, J., Li, L., Sun, X., Nguyen, L. H., Chuang, J.-C., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315490 · Cited by 85 · see citing works

The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?

Xu, S., & Tang, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.745187 · Cited by 80 · see citing works

Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice

Han, L., Madan, V., Mayakonda, A., Dakle, P., Teoh, W. W., Shyamsunder, P., Nordin, H. B. M., Cao, Z., Sundaresan, J., Lei, I., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0438-4 · Cited by 76 · see citing works

Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer

Mameishvili, E., Serafimidis, I., Iwaszkiewicz, S., Lesche, M., Reinhardt, S., Bölicke, N., Büttner, M., Stellas, D., Papadimitropoulou, A., Szabolcs, M. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901075116 · Cited by 68 · see citing works

Uncertain Beginnings: Acinar and Ductal Cell Plasticity in the Development of Pancreatic Cancer

Grimont, A., Leach, S. D., & Chandwani, R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.014 · Cited by 58 · see citing works

Arid1a restrains Kras-dependent changes in acinar cell identity

Livshits, G., Alonso-Curbelo, D., Morris, J. P., Koche, R., Saborowski, M., Wilkinson, J. E., & Lowe, S. W. (2018) · eLife · doi:10.7554/elife.35216 · Cited by 48 · see citing works

Targeting USP9X–AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma

Zhang, F.-K., Ni, Q., Wang, K., Cao, H., Guan, D., Zhang, E., Ma, N., Wang, Y., Zheng, Q., Xu, S., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.03.009 · Cited by 46 · see citing works

Next-Generation Sequencing in Pancreatic Cancer

Shen, G.-Q., Aleassa, E. M., Walsh, R. M., & Morris‐Stiff, G. J. (2019) · Pancreas · doi:10.1097/mpa.0000000000001324 · Cited by 45 · see citing works

microRNA-690 regulates induced pluripotent stem cells (iPSCs) differentiation into insulin-producing cells by targeting Sox9

Xu, Y., Huang, Y. H., Guo, Y., Xiong, Y., Zhu, S., Xu, L., Lu, J., Li, X., Wan, J., Lu, Y., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1154-8 · Cited by 44 · see citing works

The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer

Hasan, N. M., & Ahuja, N. (2019) · Cancers · doi:10.3390/cancers11121859 · Cited by 46 · see citing works

Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma

Xu, Y., Liu, J., Nipper, M. H., & Wang, P. (2019) · Annals of Pancreatic Cancer · doi:10.21037/apc.2019.06.03 · Cited by 39 · see citing works

A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination

Ideno, N., Yamaguchi, H., Okumura, T., Huang, J., Brun, M. J., Ho, M., Suh, J., Gupta, S., Maitra, A., & Ghosh, B. (2018) · bioRxiv · doi:10.1038/s41374-018-0171-z · Cited by 38 · see citing works

Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting ARID1A deficiency

Dong, X., Song, S., Li, Y., Fan, Y., Wang, L., Wang, R., Huo, L., Scott, A. W., Xu, Y., Pizzi, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322660 · Cited by 39 · see citing works

Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models

Saiki, Y., Jiang, C., Ohmuraya, M., & Furukawa, T. (2021) · Cancers · doi:10.3390/cancers14010071 · Cited by 38 · see citing works

Cholangiolocellular Carcinoma With “Ductal Plate Malformation” Pattern May Be Characterized by ARID1A Genetic Alterations

Sasaki, M., Sato, Y., & Nakanuma, Y. (2019) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001201 · Cited by 34 · see citing works

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance

Malinova, A., Veghini, L., Real, F. X., & Corbo, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.795251 · Cited by 35 · see citing works

ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression

Luo, Q., Wu, X., Chang, W., Zhao, P., Zhu, X., Chen, H., Nan, Y., Luo, A., Zhou, X., Su, D., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-18-2446 · Cited by 34 · see citing works

The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma

Tsuda, M., Fukuda, A., Kawai, M., Araki, O., & Seno, H. (2020) · Cancer Science · doi:10.1111/cas.14768 · Cited by 33 · see citing works

Uncovering the dosage-dependent roles of Arid1a in gastric tumorigenesis for combinatorial drug therapy

Loe, A. K. H., Francis, R., Seo, J., Du, L., Wang, Y., Kim, J., Hakim, S. W., Kim, J., He, H. H., Guo, H., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200219 · Cited by 30 · see citing works

Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway

Fukunaga, Y., Fukuda, A., Omatsu, M., Namikawa, M., Sono, M., Masuda, T., Araki, O., Nagao, M., Yoshikawa, T., Ogawa, S., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.04.020 · Cited by 28 · see citing works

Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer

van Roey, R., Brabletz, T., Stemmler, M. P., & Armstark, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.753456 · Cited by 25 · see citing works

Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis

Ferri-Borgogno, S., Barui, S., McGee, A. M., Griffiths, T., Singh, P. K., Piett, C. G., Ghosh, B., Bhattacharyya, S., Singhi, A., Pradhan, K., et al. (2020) · Cancers · doi:10.3390/cancers12092695 · Cited by 22 · see citing works

Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication

Hung, Y.-H., Hsu, M.-C., Chen, L.-T., Hung, W., & Pan, M.-R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060903 · Cited by 22 · see citing works

Single-PanIN-seq unveils that ARID1A deficiency promotes pancreatic tumorigenesis by attenuating KRAS-induced senescence

Liu, S., Cao, W., Niu, Y., Luo, J., Zhao, Y., Hu, Z., & Zong, C. C. (2021) · eLife · doi:10.7554/elife.64204 · Cited by 21 · see citing works

Inhibition of Arid1a increases stem/progenitor cell-like properties of liver cancer

Wang, L., Deng, C.-H., Luo, Q., Su, X., Shang, X., Song, S., Cheng, S., Qu, Y.-L., Zou, X., Shi, Y. Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215869 · Cited by 19 · see citing works

Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway

Araki, O., Tsuda, M., Omatsu, M., Namikawa, M., Sono, M., Fukunaga, Y., Masuda, T., Yoshikawa, T., Nagao, M., Ogawa, S., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02716-4 · Cited by 17 · see citing works

Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues

Voutsadakis, I. A., & Digklia, A. (2023) · Chinese Clinical Oncology · doi:10.21037/cco-22-108 · Cited by 16 · see citing works

Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Review of Their Genetic Characteristics and Mouse Models

Li, J., Wei, T., Zhang, J., & Liang, T. (2021) · Cancers · doi:10.3390/cancers13215296 · Cited by 14 · see citing works

Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications

Zhao, Z., Li, X., Wang, F., Xu, Y., Liu, S., Han, Q., Yang, Z., Huang, W., Yin, Z., Liu, Q., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.5871 · Cited by 15 · see citing works

Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis

Kato, H., Tateishi, K., Fujiwara, H., Ijichi, H., Yamamoto, K., Nakatsuka, T., Kakiuchi, M., Sano, M., Kudo, Y., Hayakawa, Y., et al. (2020) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20224 · Cited by 12 · see citing works

The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis

Li, J. J., & Lee, C. S. (2023) · Genes · doi:10.3390/genes15010005 · Cited by 15 · see citing works

Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic

Gil, Y. R., Sánchez, P. J., Velasco, R. M., García, A. G., & Lobo, V. J. S.-A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042077 · Cited by 15 · see citing works

ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance

Kuo, T.-L., Cheng, K.-H., Chen, L.-T., & Hung, W. (2022) · iScience · doi:10.1016/j.isci.2022.105881 · Cited by 14 · see citing works

The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model

Tan, M., Chang, Y., Liu, X., Li, H., Tang, Z., Nyati, M. K., & Sun, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111837 · Cited by 14 · see citing works

Remodeling of the ARID1A tumor suppressor

Luo, Q., Wu, X., & Liu, Z. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.026 · Cited by 14 · see citing works

Multidimensional chromatin profiling of zebrafish pancreas to uncover and investigate disease-relevant enhancers

Bordeira-Carriço, R., Teixeira, J., Duque, M., Galhardo, M., Ribeiro, D., Acemel, R. D., Firbas, P. N., Tena, J., Eufrásio, A., Marques, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29551-7 · Cited by 9 · see citing works

Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations

D’Ambrosio, A., Bressan, D., Ferracci, E., Carbone, F. G., Mulé, P., Rossi, F., Barbieri, C., Sorrenti, E., Fiaccadori, G., Detone, T., et al. (2024) · Science Advances · doi:10.1126/sciadv.adh4435 · Cited by 12 · see citing works

Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks

Urrutia, G., de Assuncao, T. M., Mathison, A., Salmonson, A., Kerketta, R., Zeighami, A., Stodola, T. J., Adsay, V. N., Pehlivanoğlu, B., Dwinell, M. B., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.681153 · Cited by 11 · see citing works

The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer

Weng, C., Lin, Y., & Cheng, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091369 · Cited by 12 · see citing works

Epigenetic regulator ARID1A and stem cell transcription factor SOX9 in the maintenance of pancreatic ductal cell differentiation state and development of intraductal papillary mucinous neoplasia (IPMN) and pancreatic ductal adenocarcinoma (PDAC)

Cui, N., Zhang, J., Huang, H., & Lu, L. (2018) · Translational Cancer Research · doi:10.21037/tcr.2018.07.25 · Cited by 10 · see citing works

TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma

Zhou, Y., Jin, J., Ji, Y., Zhang, J., Fu, N., Chen, M., Wang, J., Qin, K., Jiang, Y., Cheng, D., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04742-y · Cited by 10 · see citing works

Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms

Chung, W.-C., Challagundla, L., Zhou, Y., Li, M., Atfi, A., & Xu, K. (2020) · Life Science Alliance · doi:10.26508/lsa.201900503 · Cited by 9 · see citing works

Impaired ARID1A expression attenuated the immune response in gastric cancer via histone acetylation

Tang, Y., Zhang, R., Mao, G., Li, C., Gao, Y., Zhou, X., Nie, W., Song, T., Liu, S., Tao, K., et al. (2025) · Clinical Epigenetics · doi:10.1186/s13148-024-01805-9 · Cited by 9 · see citing works

NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming

Zhang, Z., Wang, X., Hamdan, F. H., Likhobabina, A., Patil, S., Aperdannier, L., Sen, M., Traub, J., Neeße, A., Fischer, A., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.01.015 · Cited by 9 · see citing works

Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm

Raut, P., Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188851 · Cited by 10 · see citing works

Cell of Origin of Pancreatic cancer

Zheng, C., Wang, J., Wang, J., Zhang, Q., & Liang, T. (2024) · Pancreas · doi:10.1097/mpa.0000000000002301 · Cited by 9 · see citing works

Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes

Patil, S., Dou, Y., & Kopp, J. L. (2021) · Visceral Medicine · doi:10.1159/000520946 · Cited by 8 · see citing works

Advances in the study of the role of high-frequency mutant subunits of the SWI/SNF complex in tumors

Zhao, J., Zhu, J., Tang, Y., Zheng, K., & Li, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1463892 · Cited by 7 · see citing works

Arid1a: A Gatekeeper in the Development of Pancreatic Cancer From a Rare Precursor Lesion

Liu, M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.046 · Cited by 7 · see citing works

Tumor Cell Plasticity in Cancer: Signaling Pathways and Pharmaceutical Interventions

Sun, S., Sun, Y., Lan, L., Luan, S., Zhou, J. R., Deng, J., Yuan, Y., & Wu, Z. (2025) · MedComm · doi:10.1002/mco2.70541 · Cited by 6 · see citing works

Targeting the alterations of ARID1A in pancreatic cancer: tumorigenesis, prediction of treatment, and prognostic value.

Li, R., Xiong, G., Zhao, J., & Yang, L. (2022) · PubMed Central · Cited by 5 · see citing works

Acvr1b Loss Increases Formation of Pancreatic Precancerous Lesions From Acinar and Ductal Cells of Origin

Saeki, K., Wood, I. S., Wang, W., Patil, S., Sun, Y., Schaeffer, D. F., Su, G. H., & Kopp, J. L. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101387 · Cited by 5 · see citing works

Arid1a deficiency sensitises pancreatic cancer to fatty acid synthase inhibition

Kuo, T., Hou, Y., Shan, Y., Chen, L., & Hung, W. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70394 · Cited by 4 · see citing works

ARID1A-mutated cervical cancer depends on the activation of YAP signaling

Gao, F., Li, P., Kong, X., Song, T., Han, Q., & Zhou, S. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5035 · Cited by 4 · see citing works

Drivers of Pancreatic Cancer: Beyond the Big 4

Porcza, L. M., Ballesteros-Cillero, R., Lam, L. T., Maiello, C., & Leslie, N. R. (2025) · Cancers · doi:10.3390/cancers17142354 · Cited by 4 · see citing works

Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma

Thompson, J. K., & Bednar, F. (2021) · Epigenomes · doi:10.3390/epigenomes5040020 · Cited by 4 · see citing works

The epipliancy journey: Tumor initiation at the mercy of identity crisis and epigenetic drift

Benhassoun, R., Morel, A., Jacquot, V., Puisieux, A., & Ouzounova, M. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189307 · Cited by 3 · see citing works

Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression

Makino, Y., Oyama, K., Sagara, A., Thege, F. I., & Maitra, A. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02328-7 · Cited by 3 · see citing works

Comprehensive Molecular Profiling of Metastatic Pancreatic Adenocarcinomas

Antony, V., Sun, T., Dolezal, D., & Cai, G. (2025) · Cancers · doi:10.3390/cancers17030335 · Cited by 3 · see citing works

KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival

Ekstrom, T. L., Dai, Z., Thiel, J., Kanakan, A., Saha, B. J., Manjunath, M., Schacherer, N., Bousounis, P., Siegler, E. L., Abdelrahman, A. M., et al. (2026) · Science Advances · doi:10.1126/sciadv.aea2106 · Cited by 2 · see citing works

The role of SWI/SNF complexes in digestive system neoplasms

Liang, H., Zheng, X., Zhang, X., Zhang, Y., & Zheng, J. (2024) · Medical Oncology · doi:10.1007/s12032-024-02343-3 · Cited by 2 · see citing works

Molecular interplay of ARID1A in gastrointestinal cancers

Athar, A., Ahmad, E., Bera, P., Nasar, M. A., Imtiyaz, K., Rizvi, M. M. A., & Saluja, S. S. (2025) · Medical Oncology · doi:10.1007/s12032-025-03014-7 · Cited by 2 · see citing works

Recent Advances in Chromatin Mechanisms Controlling Pancreatic Carcinogenesis

Hank, T. P., & Liss, A. S. (2018) · Epigenomes · doi:10.3390/epigenomes2020011 · Cited by 2 · see citing works

Cis-regulatory similarities in the zebrafish and human pancreas uncover potential disease-related enhancersPreprint

Bordeira–Carriço, R., Teixeira, J., Duque, M., Galhardo, M., Ribeiro, D., Acemel, R. D., Firbas, P., Tena, J. J., Eufrásio, A., Marques, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.27.064220 · Cited by 2 · see citing works

Pancreatic cancer patient-derived organoids capture therapy response and tumor evolutionPreprint

Gout, J., Perkhofer, L., Lindenmayer, J., Resheq, Y. J., Schwab, J. D., Kraus, J. M., Roger, É., Srinivasan, D., Zimmer, E., Mayer, B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.24.650216 · Cited by 2 · see citing works

Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation

Wu, Z., Su, X., Qin, Y., Pu, J., Xiao, S., & Zhang, X. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04207-4 · Cited by 1 · see citing works

Pancreatic plasticity: epigenetic mechanisms and connections to neoplasia

David, C. J. (2019) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000036 · Cited by 1 · see citing works

ARID1A: guardian of normal pancreatic ducts

Castellanos, K. J., & Grippo, P. J. (2019) · Translational Cancer Research · doi:10.21037/tcr.2018.12.02 · Cited by 1 · see citing works

Chromatin remodelling controls pancreatic tissue fate

Heßmann, E., & Ellenrieder, V. (2019) · Gut · doi:10.1136/gutjnl-2018-317486

Targeting the epigenome as a therapeutic strategy for pancreatic tumors

Mungamuri, S. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00011-6

Vaginal squamous cell carcinoma develops in mice with Arid1a loss and gain of oncogenic KrasPreprint

Wang, X., Praça, M. S. L., Wendel, J. R. H., Emerson, R. E., DeMayo, F. J., Lydon, J. P., & Hawkins, S. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.15.422959

Interplay of ARID1A and EGFR signaling in controlling acinar cell reprogramming in the pancreas

Zhang, Z. (2021) · doi:10.53846/goediss-8500

Charakterisierung des NF-κB Signalwegs in Arid1a defizienten Pankreaskarzinomsubtypen

Aperdannier, L. (2021) · doi:10.53846/goediss-8735

Die Rolle von ARID1A in Pankreas- und kolorektalem Karzinom

Traub, J. (2023) · doi:10.53846/goediss-9886

Acvr1b loss increases formation of pancreatic precancerous lesions from acinar and ductal cells of originPreprint

Saeki, K., Wood, I. S., Wang, W. C. K., Patil, S., Sun, Y., Schaeffer, D. F., Su, G. H., & Kopp, J. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.08.544226

Additional file 1 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma

Zhou, Y., Jin, J., Ji, Y., Zhang, J., Fu, N., Chen, M., Wang, J., Qin, K., Jiang, Y., Cheng, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24709035

Identification and Implications for Tumor Heterogeneity of a DNA Methylation-Based Signature Classifying Pancreatic Ductal Adenocarcinoma Based on their Cellular OriginPreprint

Zoi, I., Rajput, M., Holguín-Horcajo, A., Haidar, M., Brusa, D., Chu, K., Xie, J., Shields, M. A., Ferreira, S., Stanger, B. Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.642043

Contributions of Low-frequency-mutated Genes in Pancreatic Tumorigenesis and Their Implications in Precision Cancer Therapy

Hsu, S., Kuo, T., Hsu, M., & Hung, W. (2025) · Journal of Cancer Research and Practice · doi:10.4103/ejcrp.ejcrp-d-24-00040

PLK1 inhibition enhances gemcitabine-induced apoptosis through PLK1-dependent ERK1/2-Bim and AKT1/Noxa signals in pancreatic cancer cells

Lü, B., Li, H., Deng, D., & Wang, Y. (2025) · Medical Oncology · doi:10.1007/s12032-025-03062-z

Additional file 5 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma

Zhou, Y., Jin, J., Ji, Y., Zhang, J., Fu, N., Chen, M., Wang, J., Qin, K., Jiang, Y., 程东峰, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26648022

Additional file 2 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma

Zhou, Y., Jin, J., Ji, Y., Zhang, J., Fu, N., Chen, M., Wang, J., Qin, K., Jiang, Y., 程东峰, et al. (2024) · Figshare · doi:10.6084/m9.figshare.24709141

Additional file 3 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma

Zhou, Y., Jin, J., Ji, Y., Zhang, J., Fu, N., Chen, M., Wang, J., Qin, K., Jiang, Y., 程东峰, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26648016

Additional file 4 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma

Zhou, Y., Jin, J., Ji, Y., Zhang, J., Fu, N., Chen, M., Wang, J., Qin, K., Jiang, Y., 程东峰, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26648019

Epigenetic characterization of cellular pliancy in breast cancer

Benhassoun, R. (2024) · theses.fr (ABES) · doi:10.70675/0b1d39b2za3d7z4b26zb4b0zaafa77d5068a

Étude de la tumorigenèse pancréatique des tumeurs intracanalaires papillaires et mucineuses du pancréas (TIPMP)

Lorenzo, D. (2024) · doi:10.70675/ba1107b2ze1c9z4e6ezad24z3a1778a18d7e

CRISPR guided gene knockout in pancreatic ductal adenocarcinoma molecular mechanisms and therapeutic strategies

Mehmood, M. S., Noor, M., Meraj, S., Hassan, A., Ali, U., & Nazari, M. J. (2026) · Discover Oncology · doi:10.1007/s12672-026-05532-w

The roles of chromatin remodeling and 3D genome organization in cancers: from mechanistic insights to emerging treatment options

Luo, C., Xia, N., Hui, S. Y., Wong, U. S., Tsang, J. Y., Hu, H., Tsang, C. M., Lo, K. W., Sun, P., Shao, M., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02763-x

Loss of PBRM1 accelerates pancreatic cancer progression by inducing acquisition of mesenchymal phenotype and inflammatory cancer-associated fibroblasts reprogramming

Li, J., 阙日升, Zhang, J., Ma, K., Guo, S., Wen, L., Zhao, J., Chen, W., Wang, X., Qin, H., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218797

Genotype‐Informed Whole‐Animal Kinome Screening Reveals Shared Kinase Vulnerabilities Across Driver Contexts in PDAC

Hai, H., Ooshio, T., Jiang, H., Kimura, T., Satoh, Y., Hata, S., Hirata, T., Liu, J., Liu, T., Yamamura, R., et al. (2026) · Cancer Science · doi:10.1111/cas.70522

Chromatin remodeling and epigenetic reprogramming in chronic disease and cancer in the liver and pancreas

Saleh, A., Ghazal‐Aswad, K., Fernandez-Barrena, M. G., & Pin, C. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-19001-8.00025-8

SWI/SNF component <i>ARID1A</i> restrains pancreatic neoplasia formation

Wang, S. C., Nassour, I., Xiao, S., Zhang, S., Luo, X., Lee, J., Li, L., Sun, X., Nguyen, L. H., Chuang, J.-C., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315490 · Cited by 85 · see citing works

Result of Arid1a deletion on intraductal papillary mucinous neoplasm formation.

Wang, S. C. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.4_suppl.328

Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis

Ferri-Borgogno, S., Barui, S., McGee, A. M., Griffiths, T., Singh, P. K., Piett, C. G., Ghosh, B., Bhattacharyya, S., Singhi, A., Pradhan, K., et al. (2020) · Cancers · doi:10.3390/cancers12092695 · Cited by 22 · see citing works

ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas.

Wang, W., Friedland, S. C., Guo, B., O'Dell, M. R., Alexander, W. B., Whitney-Miller, C. L., Agostini-Vulaj, D., Huber, A. R., Myers, J. R., Ashton, J., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315541 · Cited by 70 · see citing works

Clinical-relevant model of intraductal papillary mucinous neoplasm induced by ARID1A loss.

Wei, T., Chen, Q., Liang, T., & Bai, X. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.e14696